设为首页 |  加入收藏
首页首页 期刊简介 消息通知 编委会 电子期刊 投稿须知 广告合作 联系我们
基于案例推理在艾滋病患者个性化治疗方案推荐中的应用

Application of case-based reasoning on personalized treatment for AIDS patients

作者: 陈婕卿  杨秋英  陈卉  黄晓婕 
单位:首都医科大学生物医学工程学院(北京100069)
关键词: 基于案例推理;聚类分析;患者相似性;数据可视化;艾滋病 
分类号:R318.04;TP311;TN911.73
出版年·卷·期(页码):2017·36·1(16-20)
摘要:

目的 探讨艾滋病患者相似性与抗病毒治疗方案之间的关系,为制定艾滋病患者个性化治疗方案提供依据。方法 收集首次接受抗病毒治疗且治疗后免疫重建良好的648例艾滋病患者临床资料,计算基于欧氏距离的患者相似性,以最相似的前10%患者治疗方案作为推荐方案,实现基于案例推理的治疗方案推荐,并通过数据可视化工具呈现基于案例推理和聚类分析的结果。结果 基于患者相似性推荐的治疗方案与实际初始治疗方案的一致率达到83.3%。结论 根据患者相似性推荐的治疗方案与实际的治疗方案之间具有较高的一致性,证实了基于案例推理和聚类分析在艾滋病患者个性化治疗方案推荐中的可行性和有效性,为艾滋病领域的精准医疗研究提供了参考。

Objective To investigate the relationship between the similarity of AIDS patients and their antiviral treatment regimens in order to provide reference to the personalized treatment for AIDS patients. Methods Clinical data of 648 AIDS patients who received highly active antiretroviral therapy with good immune reconstruction were collected. Patient similarity was calculated based on Euclidean distance. The most adopted treatment regimen among the top 10% most similar patients was regarded as the recommended regimen. Results of case-based reasoning and cluster analysis were presented by data visualization tools. Results Treatment regimens recommended on the basis of patient similarities had up to 83.3% agreement with the initial treatment regimens in practice. Conclusions Recommended treatment regimens based on the patient similarities were highly consistent with the actual regimens,confirming the feasibility and effectiveness of the case-based reasoning and cluster analysis in the personalized treatment for AIDS patients,which provided a way for the further precision medicine for AIDS patients.

参考文献:


[1]Evans MC,Paquet AC,Huang W,et al. A case-based reasoning system for genotypic prediction of HIV-1 co-receptor tropism[J]. Journal of Bioinformatics and Computational Biology,2013,11(4):136-148.

[2]Sharon W,Sarah S,Shana D,et al. Randomized controlled trial: 4 month versus 6month monitoring of HIV-infected patients on highly active antiretroviral therapy [J]. Journal of Community Health,2016,23(1):69-74. 

[3]Nkhoma ET,Coumbis J,Farr AM,et al. No evidence of an association between Efavirenz exposure and suicidality among HIV patients initiating antiretroviral therapy in a retrospective cohort study of real world data [J]. Medicine,2016,95(3):e2480.

[4]Lin He,Xiaohong Pan,Zhihui Dou,et al. The factors related to CD4+T-cell recovery and viral suppression in patients who have low CD4+T cell counts at the initiation of HAART: A retrospective study of the national HIV treatment sub-database of Zhejiang Province,China,2014 [J]. PLoS ONE,2014,11(2): e0148915. 

[5]张福杰,张晨阳.抗逆转录病毒治疗的时机和用药方案[J].中国性病艾滋病防治,2001,7(4):253-255.

Zhang Fujie,Zhang Chenyang. The time and treatment regimen of highly active antiretroviral therapy [J]. Chinese Journal of STD & AIDS Prevention and Control,2001,7(4):253-255.

[6]彭琰,严莉.基于Gephi的云南民族医药研究可视化分析[J].医学信息学杂志,2015,36(2):65-89.

Peng Yan,Yan Li. Visualization analysis of Yunnan Nationality Medicine Research based on Gephi[J]. Journal of Medical Informatics,2015,36(2):65-89.

[7]关迎晖,向勇,陈康.基于Gephi的可视化分析方法研究与应用[J].电信科学,2013,29(S1):112-119.

Guan Yinghui,Xiang Yong,Chen Kang. Study and application of visualization analysis based on Gephi [J]. Telecommunication Science,2013,29(S1):112-119.

[8]Ngene NC,Moodley J. New drug regimens for HIV in pregnancy and a national strategic plan to manage HIV: A South African perspective[J]. International Journal of Gynecology and Obstetrics,2015,131(1):S19-S22. 

[9]Dickson S,Jules C,Anna L,et al. Risk factors of cardiovascular diseases in HIV/AIDS patients on HAART  [J]. The Open AIDS Journal,2015,9(1):51-59. 

[10]徐六妹,李莎茜,吴宝红,等.对发生药物不良反应AIDS患者服药依从性的干预研究[J].中华护理杂志,2015,50(2):179-183.

Xu Liumei,Li Shaqian,Wu Baohong,et al. The effectiveness of individualized management on thee medication compliance in AIDS patients with adverse drug reactions [J]. Chinese Journal of Nursing,2015,50(2):179-183.

[11]尚明全.我国艾滋病患者应用二线抗病毒治疗方案后治疗效果和耐药性研究[D].沈阳:中国医科大学,2011:28-30.

Shang Mingquan. Study of the drug-resistance and treatment outcome in patients receiving second-line[D]. Shenyang: China Medical University,2011,28-30.


服务与反馈:
文章下载】【加入收藏
提示:您还未登录,请登录!点此登录
 
友情链接  
地址:北京安定门外安贞医院内北京生物医学工程编辑部
电话:010-64456508  传真:010-64456661
电子邮箱:llbl910219@126.com